Acute and late major adverse Cardiac events using the S7 Coronary stent

Abstract

To assess acute and late major adverse cardiac events (MACE) using the S7 coronary stent. Settings and Methods: A prospective, non-randomized trial where 406 patients with objective evidence of ischemia and a target vessel diameter ::=:3.0 mm and ::;4.0 mm underwent percutaneous intervention (PCI) using an S7 stent. Patients were assessed for acute complications and followed for MACE for up to 6 months. Result: A total of 406 patients were involved and 437 lesions were dilated. The mean age was 57 years. They were 80.8% male and 23.9% diabetic. 29.5% had prior myocardial infarction. 54.8% had type B2 +C lesions. There were no acute complications, including either acute or subacute thrombosis. All patients were dilated successfully with an increase in minimal luminal diameter from 0.7 mm ± 0.7 mm to 3.3 ± 0.6 mm (P=0.0005). Follow up at 6 months was available for 96.6% of patients. The rate of major adverse cardiac events was 8.5% and the rate of target lesion revascularization was 6.3%. Conclusion: Despite the complexity of the lesions being dilated, PCI using S7 stent has good acute angiographic results. The acute and 6-month events rate were low with optimal follow-up.